Skip to main content

Table 3 HILPs (%) collected according to stage disease

From: Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: The experience of the Tuscan Reference Centre

HILP Group

Stage

 

I

II

III

IV

G-A (n = 60)

48.4

8.3

43.3

-

G-B (n = 74)

78.3

1.3

20.4

-

G-C (n = 108)

0.9

2.7

92.7

3.7

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us